Molnlycke Holding
Mölnlycke Holding AB is a Swedish medical device manufacturer specializing in wound care and single-use surgical solutions. The company produces advanced wound care dressings, pressure ulcer prevention products, surgical gloves, drapes, and customized surgical trays under the Mölnlycke brand. Principal revenue streams are derived from direct product sales to healthcare systems, hospital procurement organizations, and medical supply distributors. Core end markets encompass acute care hospitals, surgical operating rooms, wound care centers, and long-term care facilities worldwide. Mölnlycke holds a leading global market position in advanced wound management products and single-use surgical gloves. The company is headquartered in Gothenburg, Sweden, operating as a private portfolio enterprise owned by Investor AB.
16 of the funds FundTelligence covers report a position in Molnlycke Holding.
- Legal name
- MOLNLYCKE HOLDING AB
- Sector
- Health Care
- Country
- Sweden
- Funds holding it
- 16
Funds holding Molnlycke Holding
- Cicero Yield — Cicero Fonder · 1.36 % (full portfolio disclosed, June 2026)
- Nordea Virksomhedsobligationer — Nordea Funds · 1.03 % (full portfolio disclosed, July 2026)
- Nordea Corporate Bond Fund 1-3 Years — Nordea Funds · 1.0 % (full portfolio disclosed, September 2026)
- Cicero Avkastning — Cicero Fonder · 0.94 % (full portfolio disclosed, June 2026)
- Nordea European Corporate Bond — Nordea Funds · 0.77 % (full portfolio disclosed, July 2026)
- Danske Invest Nordisk Kredittobligasjon — Danske Invest · 0.71 % (full portfolio disclosed, September 2026)
- Nordea European Corporate Sustainable Stars Bond — Nordea Funds · 0.65 % (full portfolio disclosed, July 2026)
- Nordea Euro Corporate Enhanced Bond Fund — Nordea Funds · 0.53 % (full portfolio disclosed, July 2026)
Showing the 8 largest of 16 funds holding it.